The effects of secondary prevention after coronary revascularization in Taiwan

BACKGROUND: Secondary prevention therapy for patients with coronary artery disease using an antiplatelet agent, β-blocker, renin-angiotensin system blocker (RASB), or statin plays an important role in the reduction of coronary events after coronary artery bypass grafting (CABG) surgery or percutaneo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Feng, Wen-Han, Chu, Chun-Yuan, Hsu, Po-Chao, Lee, Wen-Hsien, Su, Ho-Ming, Lin, Tsung-Hsien, Yen, Hsueh-Wei, Voon, Wen-Chol, Lai, Wen-Ter, Sheu, Sheng-Hsiung
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6497233/
https://ncbi.nlm.nih.gov/pubmed/31048901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0215811
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados